Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
07/25/2012 | EP2118110B1 Cyclopropyl fused indolobenzazepine hcv inhibitors |
07/25/2012 | EP2089401B1 Use of tri-substituted glycerol compounds for the treatment of radiation injuries |
07/25/2012 | EP2079688B1 Glucagon receptor antagonist compounds, compositions containing such compounds and their pharmaceutical use |
07/25/2012 | EP2077266B1 2-pyridinecarboxamide derivative having gk-activating activity |
07/25/2012 | EP2018170B1 Medication against breast cancer |
07/25/2012 | EP2013201B1 Heterocyclic gpcr agonists |
07/25/2012 | EP2007774B1 Thiazolyldihydroindazole derivatives as protein kinase inhibitors |
07/25/2012 | EP1989202B1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
07/25/2012 | EP1961420B1 Agent for prevention and treatment of acute renal failure |
07/25/2012 | EP1940393B1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
07/25/2012 | EP1937278B1 Antisense antiviral compound and method for treating picornavirus infection |
07/25/2012 | EP1934222B1 Pyrazolo[1, 5 -alpha]pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists |
07/25/2012 | EP1891063B1 Bicyclic derivatives as modulators of ion channels |
07/25/2012 | EP1848419B1 Injectable preparations of diclofenac and its pharmaceutically acceptable salts |
07/25/2012 | EP1811995B1 A transmucosal veterinary composition comprising detomidine |
07/25/2012 | EP1723121B1 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors |
07/25/2012 | EP1706403B9 Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment |
07/25/2012 | EP1699783B1 Opioid receptor antagonists |
07/25/2012 | EP1691814B1 Anti-inflammatory agents |
07/25/2012 | EP1684780B1 The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin |
07/25/2012 | EP1622866B1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
07/25/2012 | EP1605897B1 Polyethelene glycol link glp-1 compounds |
07/25/2012 | EP1390349B1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands |
07/25/2012 | EP1372649B1 Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors |
07/25/2012 | EP1333808B1 Electroprocessed composition used in drug delivery and cell encapsulation |
07/25/2012 | EP1322641B1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases |
07/25/2012 | EP1257544B1 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
07/25/2012 | EP1252162B1 Alpha v integrin receptor antagonists |
07/25/2012 | EP1109453B1 Compositions and methods for treatment of mitochondrial diseases |
07/25/2012 | EP0800829B2 Use of a pm-1 antibody or of a mh 166 antibody for enhancing the anti-tumor effect of cisplatin or carboplatin |
07/25/2012 | CN1901884B Solid pharmaceutical dosage form |
07/25/2012 | CN1822818B Particles containing an acitve agent in the form of a co-precipitate |
07/25/2012 | CN102612560A Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1 |
07/25/2012 | CN102612520A Spiropiperidine compounds as orl-1 receptor antagonists |
07/25/2012 | CN102612516A Substituted pyrrolidine-2-carboxamides |
07/25/2012 | CN102612515A 2-amino-9-[4-(4-methoxy-phenoxy) - piperid in -1-yl] -4-phenyl-indeno [1,2-d] pyrimidin -5 -one and its use as a highly selective adenosine a2a receptor antagonist |
07/25/2012 | CN102612514A Anti -influenza agents |
07/25/2012 | CN102612511A Thiol-containing compounds for the removal of elements from contaminated milieu and methods of use |
07/25/2012 | CN102612384A Reduced-odor polyol composition and method of producing same |
07/25/2012 | CN102612375A Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle |
07/25/2012 | CN102612372A Methods and compositions for rapid treatment of otitis externa |
07/25/2012 | CN102612371A Extracts, fractions and compositions comprising acetogenins and their applications |
07/25/2012 | CN102612370A Dietary supplement stimulating the male sexual function |
07/25/2012 | CN102612369A Anti-tumor effect potentiator |
07/25/2012 | CN102612368A Method of treating proliferative disorders and other pathological conditions mediated by Bcr-Abl, c-Kit, DDR1, DDR2 or PDGF-R kinase activity |
07/25/2012 | CN102612367A Prolyl hydroxylase inhibitors |
07/25/2012 | CN102612366A Role of N-2 hydroxy-ethyl-piperazine-N'-2-ethane sulfonic acid (HEPES) in pain control and reversal of demyelinization injury |
07/25/2012 | CN102612365A Checkpoint kinase 1 inhibitors for potentiating DNA damaging agents |
07/25/2012 | CN102612364A Use of lutein containing compositions to improve certain aspects of memory |
07/25/2012 | CN102612360A Dicyclanil-based aqueous suspension and non-aqueous solution pour-on and spray on formulations for the prevention and treatment of insect infestation in animal |
07/25/2012 | CN102612359A Oral suspension formulations of esclicarbazepine acetate |
07/25/2012 | CN102612358A Stabilised particles comprising 5-methyl-(6s)-tetrahydrofolate |
07/25/2012 | CN102612320A Virus-inactivating agent |
07/25/2012 | CN102604957A Stabilized immunomodulatory oligonucleotides |
07/25/2012 | CN102604879A Engineering bacteria for producing erythromycin and application of the engineering bacteria |
07/25/2012 | CN102603924A Method for separating sulodexide raw materials from heparin by-products |
07/25/2012 | CN102603910A Preparation method of pachyman sulfate |
07/25/2012 | CN102603906A Preparation method of inonotus obliquus polysaccharide aqueous solution |
07/25/2012 | CN102603861A Tanshinone derivatives, medicine compositions thereof, and purposes thereof in medicine |
07/25/2012 | CN102603858A Azacycle-containing derivative of betulinol, preparation method thereof, and purpose thereof |
07/25/2012 | CN102603856A Anti-tumor saponin in anemone plants and preparation method thereof as well as application |
07/25/2012 | CN102603848A Preparation method of ginsenoside Rh2 fatty acid diester, and medicinal use of the ginsenoside Rh2 fatty acid diester |
07/25/2012 | CN102603847A Preparation method and medicinal application of ginsenoside Rh2 aliphatic ester compound |
07/25/2012 | CN102603836A Schisandrin C simplifier, schisandrin analogue, preparation method and applications thereof |
07/25/2012 | CN102603827A Paeoniflorin aromatic ester derivative, preparation method and applications thereof |
07/25/2012 | CN102603826A Method for extracting 8-acetylharpagide from decumbent bugle herb plant |
07/25/2012 | CN102603825A New 5-thioxylopyranose derivatives |
07/25/2012 | CN102603824A New 3'-azido daunorubicin-13-thiosemicarbazone compound with cancer resistance and preparation method thereof |
07/25/2012 | CN102603818A Preparation method and use of cerebroside compounds |
07/25/2012 | CN102603812A Binuclear platinum (II)-zoledronate complex and preparation and application thereof |
07/25/2012 | CN102603804A Novel platinum complex, preparation method and applications of platinum complex |
07/25/2012 | CN102603783A Targeted malignant tumor resistance medicament and preparation method thereof |
07/25/2012 | CN102603769A Sulfur-containing chromone compound and preparation method thereof and application in preparation of antitumor drugs |
07/25/2012 | CN102603766A Preparation method and application of tamoxifen twin drug |
07/25/2012 | CN102603765A Method for extracting active ingredients of Euphorbia fischeriana and diterpenoid medicament prepared by active ingredients |
07/25/2012 | CN102603763A Method for extracting lignans compounds from Radix Clematidis and application |
07/25/2012 | CN102603761A Etoposide compound with hydroxamic acid structure and preparation method and usage thereof |
07/25/2012 | CN102603759A Camptothecin E ring analogues and applications thereof as drugs |
07/25/2012 | CN102603755A Compound with synergetic effect with fluconazole in resisting drug-resisting fungi |
07/25/2012 | CN102603753A Isomers of hemoporfin |
07/25/2012 | CN102603751A Triazol (4,5-D) pyrimidine derivate and preparation method of triazol (4,5-D) pyrimidine derivate as well as application of triazol (4,5-D) pyrimidine derivate in drug preparation |
07/25/2012 | CN102603746A Carbapenem derivative |
07/25/2012 | CN102603743A Anti-tumor benzazepine[f]azulene derivative, preparation method thereof, and purpose thereof |
07/25/2012 | CN102603738A Stable moxifloxacin hydrochloride compound |
07/25/2012 | CN102603737A Pyridopyrimidine ketones derivative and application in preparing antitumor drugs thereof |
07/25/2012 | CN102603734A Protein kinase inhibitor and application thereof |
07/25/2012 | CN102603731A New quinolone derivative |
07/25/2012 | CN102603728A 4-alkyl-2-aryl amino-5-(1,2,4-triazol-1-yl)thiazole and preparation method and application thereof |
07/25/2012 | CN102603723A Azilsartan organic amine salts, and preparation method and application thereof |
07/25/2012 | CN102603719A Novel compound of 2-furylcarbinol-(5'-11)-1,3-cyclopentadiene [5,4-c]-1H-cinnoline and application of novel compound as antioxidant to food, cosmetics or medicine |
07/25/2012 | CN102603717A Pyrrylketone compound and application thereof as drug |
07/25/2012 | CN102603713A Chiral CB1 (cannabinoid) receptor inhibitor, and preparation method and medical application thereof |
07/25/2012 | CN102603712A S-type and R-type tetrahydro-naphthalene amides antitumor compound and pharmaceutically acceptable salt or pro-drug thereof, preparation method and application |
07/25/2012 | CN102603711A Pyridine carboxamides as 11-beta-hsd1 inhibitors |
07/25/2012 | CN102603698A Scutellarin carbamate derivative, preparation method and use thereof |
07/25/2012 | CN102603694A Novel synthesis method of murrayone and novel application of murrayone |
07/25/2012 | CN102603692A Chroman and chromene derivatives as tumor multidrug resistance inhibitor as well as preparation method and application of chroman and chromene derivatives |
07/25/2012 | CN102603691A Method for manufacturing neuraminic acid derivatives |
07/25/2012 | CN102603689A Norditerpenoid compound Lachnin A, and preparation method and application thereof |
07/25/2012 | CN102603685A Flavonoid fatty acid ester derivatives, preparation method and medicinal use of flavonoid fatty acid ester derivatives |